| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 3.21e-08 | 20 | 95 | 5 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 7.35e-07 | 36 | 95 | 5 | GO:0019789 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 3.92e-06 | 50 | 95 | 5 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 5.25e-06 | 53 | 95 | 5 | GO:0016859 | |
| GeneOntologyMolecularFunction | GTPase binding | RGPD4 RGPD2 RANBP2 RANGAP1 RGPD8 DOCK11 PTPRN SYTL5 RAB3GAP2 RGPD3 | 8.31e-06 | 360 | 95 | 10 | GO:0051020 |
| GeneOntologyMolecularFunction | small GTPase binding | RGPD4 RGPD2 RANBP2 RANGAP1 RGPD8 DOCK11 SYTL5 RAB3GAP2 RGPD3 | 2.24e-05 | 321 | 95 | 9 | GO:0031267 |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 6.70e-05 | 3 | 95 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 RGPD2 RANBP2 RANGAP1 RGPD8 DOCK11 DENND4C FARP2 RAB3GAP2 RGPD3 | 1.49e-04 | 507 | 95 | 10 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 RGPD2 RANBP2 RANGAP1 RGPD8 DOCK11 DENND4C FARP2 RAB3GAP2 RGPD3 | 1.49e-04 | 507 | 95 | 10 | GO:0030695 |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 2.22e-04 | 5 | 95 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | histone H3K36 trimethyltransferase activity | 2.22e-04 | 5 | 95 | 2 | GO:0140955 | |
| GeneOntologyMolecularFunction | isomerase activity | 3.12e-04 | 192 | 95 | 6 | GO:0016853 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 3.74e-04 | 279 | 95 | 7 | GO:0005096 | |
| GeneOntologyMolecularFunction | enzyme activator activity | RGPD4 RGPD2 RANBP2 RANGAP1 RGPD8 PARP8 BAD RFC1 RAB3GAP2 RGPD3 | 1.12e-03 | 656 | 95 | 10 | GO:0008047 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.58e-03 | 262 | 95 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 1.69e-03 | 13 | 95 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | molecular function activator activity | RGPD4 GDF5 RGPD2 RANBP2 RANGAP1 RGPD8 PARP8 BAD RFC1 PTK2 BLM RAB3GAP2 RGPD3 C1QTNF4 | 2.03e-03 | 1233 | 95 | 14 | GO:0140677 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 8.18e-13 | 9 | 98 | 6 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 2.04e-12 | 10 | 98 | 6 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.65e-11 | 13 | 98 | 6 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 2.87e-11 | 14 | 98 | 6 | GO:1903299 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 3.20e-08 | 20 | 98 | 5 | GO:0006607 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 9.68e-07 | 38 | 98 | 5 | GO:0000413 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 2.13e-06 | 178 | 98 | 8 | GO:0051236 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 5.74e-06 | 54 | 98 | 5 | GO:0018208 | |
| GeneOntologyBiologicalProcess | RNA localization | 9.22e-06 | 217 | 98 | 8 | GO:0006403 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 2.22e-05 | 71 | 98 | 5 | GO:0006111 | |
| GeneOntologyBiologicalProcess | telomerase catalytic core complex assembly | 2.23e-05 | 2 | 98 | 2 | GO:1904868 | |
| GeneOntologyBiologicalProcess | positive regulation of telomerase catalytic core complex assembly | 2.23e-05 | 2 | 98 | 2 | GO:1904884 | |
| GeneOntologyBiologicalProcess | regulation of telomerase catalytic core complex assembly | 2.23e-05 | 2 | 98 | 2 | GO:1904882 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 2.49e-05 | 249 | 98 | 8 | GO:0015931 | |
| GeneOntologyBiologicalProcess | nuclear export | 2.90e-05 | 185 | 98 | 7 | GO:0051168 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 4.33e-05 | 134 | 98 | 6 | GO:0010906 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization to telomere | 6.68e-05 | 3 | 98 | 2 | GO:0097694 | |
| GeneOntologyBiologicalProcess | establishment of protein-containing complex localization to telomere | 6.68e-05 | 3 | 98 | 2 | GO:0097695 | |
| GeneOntologyBiologicalProcess | mRNA transport | 6.73e-05 | 145 | 98 | 6 | GO:0051028 | |
| GeneOntologyBiologicalProcess | positive regulation of protein acetylation | 8.06e-05 | 18 | 98 | 3 | GO:1901985 | |
| GeneOntologyBiologicalProcess | positive regulation of synapse structural plasticity | 1.33e-04 | 4 | 98 | 2 | GO:0051835 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 1.88e-04 | 111 | 98 | 5 | GO:0006094 | |
| GeneOntologyBiologicalProcess | RNA transport | 1.89e-04 | 175 | 98 | 6 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.89e-04 | 175 | 98 | 6 | GO:0050657 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 2.22e-04 | 115 | 98 | 5 | GO:0019319 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | FRMPD4 ATR DOCK11 BAD CASP7 SHOC2 ZNF804A SHANK3 PTK2 FBXO38 RAB3GAP2 ELAPOR1 GOLGA8B CEP295 LRRC7 ATM SLITRK6 | 2.24e-04 | 1366 | 98 | 17 | GO:0051130 |
| GeneOntologyBiologicalProcess | DNA repair | 2.54e-04 | 648 | 98 | 11 | GO:0006281 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 2.81e-04 | 121 | 98 | 5 | GO:0046364 | |
| GeneOntologyBiologicalProcess | regulation of protein acetylation | 3.13e-04 | 28 | 98 | 3 | GO:1901983 | |
| GeneOntologyBiologicalProcess | telomerase holoenzyme complex assembly | 3.31e-04 | 6 | 98 | 2 | GO:1905323 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle | 3.97e-04 | 282 | 98 | 7 | GO:0045930 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 4.20e-04 | 132 | 98 | 5 | GO:0043255 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-lysine acetylation | 4.62e-04 | 7 | 98 | 2 | GO:2000758 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD4 RGPD2 RANBP2 RANGAP1 REPS1 RGPD8 PTK2 SETD2 VPS52 SYTL5 RAB3GAP2 RGPD3 GOLGA8B LRRC7 REPS2 AGTPBP1 DOP1B | 6.41e-04 | 1496 | 98 | 17 | GO:0046907 |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair via homologous recombination | 6.61e-04 | 83 | 98 | 4 | GO:0010569 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 6.64e-04 | 146 | 98 | 5 | GO:2000779 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | RGPD4 DIP2B RGPD2 RANBP2 RANGAP1 RGPD8 ATR PTK2 DIP2A SETD2 RGPD3 ATM AGTPBP1 | 7.10e-04 | 976 | 98 | 13 | GO:0018193 |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 8.26e-04 | 231 | 98 | 6 | GO:0006109 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 8.83e-04 | 234 | 98 | 6 | GO:0006282 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 9.02e-04 | 324 | 98 | 7 | GO:0006302 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.37e-13 | 8 | 97 | 6 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.77e-12 | 10 | 97 | 6 | GO:0044614 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 4.38e-10 | 21 | 97 | 6 | GO:0106068 | |
| GeneOntologyCellularComponent | annulate lamellae | 3.75e-09 | 14 | 97 | 5 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.58e-08 | 18 | 97 | 5 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 2.84e-08 | 20 | 97 | 5 | GO:0042405 | |
| GeneOntologyCellularComponent | inclusion body | 3.88e-06 | 90 | 97 | 6 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear pore | 7.59e-06 | 101 | 97 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 RGPD2 RANBP2 RANGAP1 CALR3 RGPD8 ATR PARP8 RIF1 RGPD3 SH3BGRL2 | 5.74e-05 | 560 | 97 | 11 | GO:0005635 |
| GeneOntologyCellularComponent | nuclear membrane | 2.21e-04 | 349 | 97 | 8 | GO:0031965 | |
| GeneOntologyCellularComponent | site of DNA damage | 4.47e-04 | 137 | 97 | 5 | GO:0090734 | |
| GeneOntologyCellularComponent | replication fork | 4.55e-04 | 77 | 97 | 4 | GO:0005657 | |
| GeneOntologyCellularComponent | dendritic spine | 9.29e-04 | 242 | 97 | 6 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 1.03e-03 | 247 | 97 | 6 | GO:0044309 | |
| GeneOntologyCellularComponent | site of double-strand break | 1.26e-03 | 101 | 97 | 4 | GO:0035861 | |
| MousePheno | abnormal morula morphology | 6.58e-09 | 26 | 81 | 6 | MP:0012058 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 2.40e-08 | 16 | 81 | 5 | MP:0003701 | |
| MousePheno | decreased tumor latency | 7.33e-07 | 30 | 81 | 5 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 8.70e-07 | 31 | 81 | 5 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 1.41e-06 | 34 | 81 | 5 | MP:0010307 | |
| MousePheno | abnormal blastocyst formation | 2.84e-06 | 39 | 81 | 5 | MP:0012128 | |
| MousePheno | increased hepatocellular carcinoma incidence | 3.06e-06 | 70 | 81 | 6 | MP:0003331 | |
| MousePheno | abnormal mitosis | 9.07e-06 | 128 | 81 | 7 | MP:0004046 | |
| MousePheno | aneuploidy | 2.66e-05 | 61 | 81 | 5 | MP:0004024 | |
| MousePheno | increased sarcoma incidence | 2.71e-05 | 102 | 81 | 6 | MP:0002032 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 3.56e-05 | 107 | 81 | 6 | MP:0003694 | |
| MousePheno | increased hepatobiliary system tumor incidence | 4.38e-05 | 111 | 81 | 6 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 4.38e-05 | 111 | 81 | 6 | MP:0008019 | |
| MousePheno | abnormal blastocyst hatching | 4.84e-05 | 113 | 81 | 6 | MP:0003693 | |
| MousePheno | abnormal preimplantation embryo development | 5.89e-05 | 171 | 81 | 7 | MP:0009781 | |
| MousePheno | increased incidence of induced tumors | 6.34e-05 | 173 | 81 | 7 | MP:0002021 | |
| MousePheno | abnormal rod electrophysiology | 6.47e-05 | 119 | 81 | 6 | MP:0004021 | |
| MousePheno | increased lung carcinoma incidence | 8.74e-05 | 78 | 81 | 5 | MP:0008714 | |
| MousePheno | abnormal chromosome morphology | 8.89e-05 | 126 | 81 | 6 | MP:0003702 | |
| MousePheno | abnormal cell nucleus morphology | 9.34e-05 | 184 | 81 | 7 | MP:0003111 | |
| MousePheno | abnormal chromosome number | 1.39e-04 | 86 | 81 | 5 | MP:0004023 | |
| MousePheno | increased carcinoma incidence | 1.43e-04 | 197 | 81 | 7 | MP:0002038 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 1.72e-04 | 203 | 81 | 7 | MP:0011094 | |
| MousePheno | abnormal eye physiology | RGPD4 CDKN1C RGPD2 RANBP2 RGPD8 DSG3 ASH1L SHANK3 RGPD3 SLITRK6 MUC5AC AGTPBP1 | 1.81e-04 | 606 | 81 | 12 | MP:0005253 |
| MousePheno | abnormal preimplantation embryo morphology | 2.29e-04 | 283 | 81 | 8 | MP:0014137 | |
| MousePheno | enlarged epididymis | 2.69e-04 | 99 | 81 | 5 | MP:0004931 | |
| MousePheno | increased classified tumor incidence | 3.49e-04 | 381 | 81 | 9 | MP:0010273 | |
| MousePheno | abnormal classified tumor incidence | 3.69e-04 | 384 | 81 | 9 | MP:0020188 | |
| MousePheno | increased respiratory system tumor incidence | 3.86e-04 | 107 | 81 | 5 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 3.86e-04 | 107 | 81 | 5 | MP:0008014 | |
| MousePheno | increased malignant tumor incidence | 4.41e-04 | 237 | 81 | 7 | MP:0002018 | |
| MousePheno | increased organ/body region tumor incidence | 4.54e-04 | 395 | 81 | 9 | MP:0010274 | |
| MousePheno | embryonic lethality before implantation | 5.00e-04 | 242 | 81 | 7 | MP:0006204 | |
| MousePheno | abnormal organ/body region tumor incidence | 5.06e-04 | 401 | 81 | 9 | MP:0013152 | |
| MousePheno | abnormal embryo development | RGPD4 CDKN1C FLII RGPD2 RANBP2 RANGAP1 RGPD8 RFC1 PTK2 DDX10 BLM RIF1 SETD2 TENM4 RBM19 RGPD3 SLC25A19 BICC1 | 7.06e-04 | 1370 | 81 | 18 | MP:0001672 |
| MousePheno | abnormal cell cycle | 8.15e-04 | 520 | 81 | 10 | MP:0003077 | |
| MousePheno | abnormal incidence of induced tumors | 9.34e-04 | 269 | 81 | 7 | MP:0013151 | |
| MousePheno | abnormal epididymis morphology | 9.34e-04 | 269 | 81 | 7 | MP:0002631 | |
| MousePheno | increased tumor incidence | 9.43e-04 | 530 | 81 | 10 | MP:0002020 | |
| MousePheno | abnormal testis development | 9.85e-04 | 34 | 81 | 3 | MP:0003830 | |
| Domain | Ran_BP1 | 2.62e-09 | 12 | 97 | 5 | PF00638 | |
| Domain | RANBD1 | 2.62e-09 | 12 | 97 | 5 | PS50196 | |
| Domain | RanBD | 4.24e-09 | 13 | 97 | 5 | SM00160 | |
| Domain | Ran_bind_dom | 4.24e-09 | 13 | 97 | 5 | IPR000156 | |
| Domain | GCC2_Rab_bind | 2.36e-08 | 7 | 97 | 4 | IPR032023 | |
| Domain | Rab_bind | 2.36e-08 | 7 | 97 | 4 | PF16704 | |
| Domain | - | 1.40e-07 | 10 | 97 | 4 | 1.10.220.60 | |
| Domain | Grip | 2.19e-07 | 11 | 97 | 4 | SM00755 | |
| Domain | GRIP | 2.19e-07 | 11 | 97 | 4 | PF01465 | |
| Domain | GRIP_dom | 3.28e-07 | 12 | 97 | 4 | IPR000237 | |
| Domain | GRIP | 3.28e-07 | 12 | 97 | 4 | PS50913 | |
| Domain | PH_dom-like | RGPD4 RGPD2 RANBP2 FRMPD4 RGPD8 DOCK11 PTK2 FARP2 RGPD3 SNTG2 | 7.36e-05 | 426 | 97 | 10 | IPR011993 |
| Domain | Desmoglein | 1.59e-04 | 4 | 97 | 2 | IPR009123 | |
| Domain | AWS | 2.64e-04 | 5 | 97 | 2 | SM00570 | |
| Domain | AWS | 2.64e-04 | 5 | 97 | 2 | PS51215 | |
| Domain | FATC | 2.64e-04 | 5 | 97 | 2 | PF02260 | |
| Domain | AWS_dom | 2.64e-04 | 5 | 97 | 2 | IPR006560 | |
| Domain | DMAP_binding | 2.64e-04 | 5 | 97 | 2 | PF06464 | |
| Domain | Cadherin_cytoplasmic-dom | 2.87e-04 | 25 | 97 | 3 | IPR000233 | |
| Domain | Cadherin_C | 2.87e-04 | 25 | 97 | 3 | PF01049 | |
| Domain | FAT | 3.95e-04 | 6 | 97 | 2 | PS51189 | |
| Domain | FATC | 3.95e-04 | 6 | 97 | 2 | PS51190 | |
| Domain | DMAP1-bd | 3.95e-04 | 6 | 97 | 2 | IPR010506 | |
| Domain | FAT | 3.95e-04 | 6 | 97 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 3.95e-04 | 6 | 97 | 2 | IPR003151 | |
| Domain | FATC_dom | 3.95e-04 | 6 | 97 | 2 | IPR003152 | |
| Domain | PIK_FAT | 3.95e-04 | 6 | 97 | 2 | IPR014009 | |
| Domain | DMAP_binding | 3.95e-04 | 6 | 97 | 2 | SM01137 | |
| Domain | FATC | 3.95e-04 | 6 | 97 | 2 | SM01343 | |
| Domain | Catenin_binding_dom | 4.50e-04 | 29 | 97 | 3 | IPR027397 | |
| Domain | - | 4.50e-04 | 29 | 97 | 3 | 4.10.900.10 | |
| Domain | Desmosomal_cadherin | 5.51e-04 | 7 | 97 | 2 | IPR009122 | |
| Domain | TPR | 5.64e-04 | 129 | 97 | 5 | SM00028 | |
| Domain | TPR_repeat | 6.48e-04 | 133 | 97 | 5 | IPR019734 | |
| Domain | - | 7.37e-04 | 207 | 97 | 6 | 1.25.40.10 | |
| Domain | PDZ | 8.44e-04 | 141 | 97 | 5 | PF00595 | |
| Domain | LRR_1 | 9.88e-04 | 219 | 97 | 6 | PF00560 | |
| Domain | PDZ | 1.05e-03 | 148 | 97 | 5 | SM00228 | |
| Domain | - | 1.11e-03 | 150 | 97 | 5 | 2.30.42.10 | |
| Domain | TPR-contain_dom | 1.11e-03 | 150 | 97 | 5 | IPR013026 | |
| Domain | PDZ | 1.15e-03 | 151 | 97 | 5 | PS50106 | |
| Domain | EF-hand_4 | 1.17e-03 | 10 | 97 | 2 | PF12763 | |
| Domain | PDZ | 1.18e-03 | 152 | 97 | 5 | IPR001478 | |
| Domain | TPR-like_helical_dom | 1.36e-03 | 233 | 97 | 6 | IPR011990 | |
| Domain | - | 1.42e-03 | 321 | 97 | 7 | 3.80.10.10 | |
| Domain | EH | 1.42e-03 | 11 | 97 | 2 | PS50031 | |
| Domain | EH | 1.42e-03 | 11 | 97 | 2 | SM00027 | |
| Domain | EH_dom | 1.42e-03 | 11 | 97 | 2 | IPR000261 | |
| Domain | L_dom-like | 1.61e-03 | 328 | 97 | 7 | IPR032675 | |
| Domain | TPR_REGION | 1.70e-03 | 165 | 97 | 5 | PS50293 | |
| Domain | TPR | 1.70e-03 | 165 | 97 | 5 | PS50005 | |
| Domain | TIL | 1.70e-03 | 12 | 97 | 2 | PF01826 | |
| Domain | HTH_Psq | 1.70e-03 | 12 | 97 | 2 | IPR007889 | |
| Domain | C8 | 1.70e-03 | 12 | 97 | 2 | PF08742 | |
| Domain | HTH_PSQ | 1.70e-03 | 12 | 97 | 2 | PS50960 | |
| Domain | FERM_M | 1.75e-03 | 46 | 97 | 3 | PF00373 | |
| Domain | ARM-type_fold | 1.94e-03 | 339 | 97 | 7 | IPR016024 | |
| Domain | Unchr_dom_Cys-rich | 2.01e-03 | 13 | 97 | 2 | IPR014853 | |
| Domain | C8 | 2.01e-03 | 13 | 97 | 2 | SM00832 | |
| Domain | FERM_central | 2.10e-03 | 49 | 97 | 3 | IPR019748 | |
| Domain | FERM_domain | 2.10e-03 | 49 | 97 | 3 | IPR000299 | |
| Domain | FERM_1 | 2.23e-03 | 50 | 97 | 3 | PS00660 | |
| Domain | FERM_2 | 2.23e-03 | 50 | 97 | 3 | PS00661 | |
| Domain | FERM_3 | 2.23e-03 | 50 | 97 | 3 | PS50057 | |
| Domain | Band_41_domain | 2.23e-03 | 50 | 97 | 3 | IPR019749 | |
| Domain | B41 | 2.23e-03 | 50 | 97 | 3 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 2.23e-03 | 50 | 97 | 3 | IPR014352 | |
| Domain | TIL_dom | 2.33e-03 | 14 | 97 | 2 | IPR002919 | |
| Domain | PI3/4_kinase_CS | 2.68e-03 | 15 | 97 | 2 | IPR018936 | |
| Domain | Leu-rich_rpt | 2.90e-03 | 271 | 97 | 6 | IPR001611 | |
| Domain | Post-SET_dom | 3.06e-03 | 16 | 97 | 2 | IPR003616 | |
| Domain | VWD | 3.06e-03 | 16 | 97 | 2 | SM00216 | |
| Domain | PostSET | 3.06e-03 | 16 | 97 | 2 | SM00508 | |
| Domain | VWF_type-D | 3.06e-03 | 16 | 97 | 2 | IPR001846 | |
| Domain | - | 3.06e-03 | 16 | 97 | 2 | 1.10.1070.11 | |
| Domain | VWFD | 3.06e-03 | 16 | 97 | 2 | PS51233 | |
| Domain | PI3Kc | 3.06e-03 | 16 | 97 | 2 | SM00146 | |
| Domain | POST_SET | 3.06e-03 | 16 | 97 | 2 | PS50868 | |
| Domain | VWD | 3.06e-03 | 16 | 97 | 2 | PF00094 | |
| Domain | PI3/4_kinase_cat_dom | 3.87e-03 | 18 | 97 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 3.87e-03 | 18 | 97 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 3.87e-03 | 18 | 97 | 2 | PS50290 | |
| Domain | CTCK_1 | 3.87e-03 | 18 | 97 | 2 | PS01185 | |
| Domain | PI3_4_KINASE_1 | 3.87e-03 | 18 | 97 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 3.87e-03 | 18 | 97 | 2 | PS00916 | |
| Domain | LRR | 3.98e-03 | 201 | 97 | 5 | PS51450 | |
| Domain | - | 4.27e-03 | 391 | 97 | 7 | 2.30.29.30 | |
| Domain | VWC_out | 4.31e-03 | 19 | 97 | 2 | SM00215 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 3.01e-10 | 18 | 74 | 6 | MM1549 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.54e-07 | 51 | 74 | 6 | MM15151 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 1.71e-06 | 70 | 74 | 6 | M27570 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.98e-06 | 40 | 74 | 5 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.25e-06 | 41 | 74 | 5 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.54e-06 | 42 | 74 | 5 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.86e-06 | 43 | 74 | 5 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 4.49e-06 | 47 | 74 | 5 | MM14939 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 5.01e-06 | 84 | 74 | 6 | MM14929 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 5.54e-06 | 49 | 74 | 5 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 6.13e-06 | 50 | 74 | 5 | MM14610 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 9.86e-06 | 55 | 74 | 5 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.28e-05 | 58 | 74 | 5 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.28e-05 | 58 | 74 | 5 | MM14736 | |
| Pathway | REACTOME_CELL_CYCLE | RGPD4 CDKN1C RGPD2 RANBP2 RANGAP1 RGPD8 RBL1 RFC1 BLM RGPD3 GOLGA8B ATM CDK7 | 1.33e-05 | 603 | 74 | 13 | MM14635 |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 1.37e-05 | 100 | 74 | 6 | MM14561 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 1.40e-05 | 59 | 74 | 5 | MM15283 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 2.25e-05 | 65 | 74 | 5 | MM15147 | |
| Pathway | REACTOME_SUMOYLATION | 2.88e-05 | 169 | 74 | 7 | MM14919 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 2.90e-05 | 114 | 74 | 6 | MM15361 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 2.99e-05 | 170 | 74 | 7 | M27582 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 3.36e-05 | 117 | 74 | 6 | MM15387 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 3.95e-05 | 73 | 74 | 5 | MM14948 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 4.05e-05 | 37 | 74 | 4 | MM14488 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 4.51e-05 | 38 | 74 | 4 | M495 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 5.82e-05 | 129 | 74 | 6 | MM14894 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 6.93e-05 | 82 | 74 | 5 | MM15394 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 8.46e-05 | 271 | 74 | 8 | MM15388 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 8.70e-05 | 86 | 74 | 5 | MM15413 | |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | 9.17e-05 | 140 | 74 | 6 | M27584 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 9.54e-05 | 141 | 74 | 6 | MM15266 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 9.92e-05 | 142 | 74 | 6 | MM15178 | |
| Pathway | BIOCARTA_CHEMICAL_PATHWAY | 1.07e-04 | 18 | 74 | 3 | M3873 | |
| Pathway | WP_INTEGRATED_CANCER_PATHWAY | 1.14e-04 | 48 | 74 | 4 | M39628 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 1.16e-04 | 146 | 74 | 6 | MM15292 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.20e-04 | 92 | 74 | 5 | MM14951 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 1.24e-04 | 49 | 74 | 4 | MM15448 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 1.57e-04 | 52 | 74 | 4 | M2341 | |
| Pathway | WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM | 1.95e-04 | 55 | 74 | 4 | M39598 | |
| Pathway | REACTOME_APOPTOSIS | 2.55e-04 | 108 | 74 | 5 | MM14471 | |
| Pathway | BIOCARTA_RAN_PATHWAY | 2.69e-04 | 5 | 74 | 2 | M22082 | |
| Pathway | WP_G1_TO_S_CELL_CYCLE_CONTROL | 2.91e-04 | 61 | 74 | 4 | MM15912 | |
| Pathway | REACTOME_DNA_REPAIR | 3.39e-04 | 332 | 74 | 8 | M15434 | |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | 3.55e-04 | 116 | 74 | 5 | MM15294 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 3.92e-04 | 257 | 74 | 7 | MM14755 | |
| Pathway | WP_CELL_CYCLE | 4.14e-04 | 120 | 74 | 5 | M39650 | |
| Pathway | WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK | 4.14e-04 | 120 | 74 | 5 | M40049 | |
| Pathway | KEGG_CELL_CYCLE | 5.00e-04 | 125 | 74 | 5 | M7963 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 5.21e-04 | 193 | 74 | 6 | MM14890 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RGPD4 RGPD2 RANBP2 RANGAP1 RGPD8 DSG1 DOCK11 PTK2 FARP2 RGPD3 GOLGA8B | 5.37e-04 | 649 | 74 | 11 | MM15690 |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 5.62e-04 | 31 | 74 | 3 | M39476 | |
| Pathway | PID_E2F_PATHWAY | 5.79e-04 | 73 | 74 | 4 | M40 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 6.17e-04 | 32 | 74 | 3 | M39567 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 6.63e-04 | 202 | 74 | 6 | MM15362 | |
| Pathway | BIOCARTA_PLK3_PATHWAY | 7.46e-04 | 8 | 74 | 2 | M22021 | |
| Pathway | WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 7.46e-04 | 8 | 74 | 2 | M42528 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 8.05e-04 | 35 | 74 | 3 | MM15293 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 8.32e-04 | 211 | 74 | 6 | M27436 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 9.49e-04 | 37 | 74 | 3 | M27583 | |
| Pathway | REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA | 9.49e-04 | 37 | 74 | 3 | M27568 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M | 9.56e-04 | 9 | 74 | 2 | M47586 | |
| Pathway | REACTOME_DNA_REPAIR | 9.99e-04 | 301 | 74 | 7 | MM15433 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M | 1.19e-03 | 10 | 74 | 2 | M47572 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | 1.19e-03 | 10 | 74 | 2 | MM14956 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 1.42e-03 | 234 | 74 | 6 | MM14898 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.45e-03 | 11 | 74 | 2 | M22027 | |
| Pathway | BIOCARTA_NPC_PATHWAY | 1.45e-03 | 11 | 74 | 2 | M22033 | |
| Pathway | PID_RANBP2_PATHWAY | 1.45e-03 | 11 | 74 | 2 | M140 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | 1.45e-03 | 11 | 74 | 2 | M9990 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 1.47e-03 | 43 | 74 | 3 | M27588 | |
| Pathway | REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1 | 1.58e-03 | 44 | 74 | 3 | MM15377 | |
| Pathway | REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1 | 1.91e-03 | 47 | 74 | 3 | M29724 | |
| Pathway | WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE | 1.91e-03 | 47 | 74 | 3 | M39518 | |
| Pathway | PID_FANCONI_PATHWAY | 1.91e-03 | 47 | 74 | 3 | M1 | |
| Pathway | KEGG_MEDICUS_REFERENCE_INTRINSIC_APOPTOTIC_PATHWAY | 2.04e-03 | 13 | 74 | 2 | M47434 | |
| Pathway | REACTOME_DISEASES_OF_DNA_REPAIR | 2.41e-03 | 51 | 74 | 3 | M29854 | |
| Pathway | REACTOME_APOPTOSIS | 2.48e-03 | 179 | 74 | 5 | M15303 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 2.65e-03 | 110 | 74 | 4 | M48043 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 2.73e-03 | 15 | 74 | 2 | M12101 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 2.73e-03 | 15 | 74 | 2 | M1262 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 2.73e-03 | 15 | 74 | 2 | MM14959 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P300_P21_CELL_CYCLE_G1_S | 2.73e-03 | 15 | 74 | 2 | M47524 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 2.73e-03 | 15 | 74 | 2 | MM14961 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.97e-03 | 271 | 74 | 6 | MM15406 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 3.30e-03 | 277 | 74 | 6 | MM15414 | |
| Pathway | WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY | 3.51e-03 | 17 | 74 | 2 | M39666 | |
| Pubmed | 8.92e-14 | 10 | 98 | 6 | 27160050 | ||
| Pubmed | 1.96e-13 | 11 | 98 | 6 | 34110283 | ||
| Pubmed | 3.35e-12 | 7 | 98 | 5 | 9037092 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 3.35e-12 | 7 | 98 | 5 | 11353387 | |
| Pubmed | 3.35e-12 | 7 | 98 | 5 | 30944974 | ||
| Pubmed | 3.35e-12 | 7 | 98 | 5 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 3.35e-12 | 7 | 98 | 5 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 3.35e-12 | 7 | 98 | 5 | 17372272 | |
| Pubmed | 3.35e-12 | 7 | 98 | 5 | 38657106 | ||
| Pubmed | 3.35e-12 | 7 | 98 | 5 | 21205196 | ||
| Pubmed | 3.35e-12 | 7 | 98 | 5 | 18949001 | ||
| Pubmed | 3.35e-12 | 7 | 98 | 5 | 25187515 | ||
| Pubmed | 3.35e-12 | 7 | 98 | 5 | 8603673 | ||
| Pubmed | 3.35e-12 | 7 | 98 | 5 | 26632511 | ||
| Pubmed | 3.35e-12 | 7 | 98 | 5 | 24403063 | ||
| Pubmed | 3.35e-12 | 7 | 98 | 5 | 23818861 | ||
| Pubmed | 3.35e-12 | 7 | 98 | 5 | 23536549 | ||
| Pubmed | 3.35e-12 | 7 | 98 | 5 | 12191015 | ||
| Pubmed | 3.35e-12 | 7 | 98 | 5 | 22821000 | ||
| Pubmed | 3.35e-12 | 7 | 98 | 5 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 8.91e-12 | 8 | 98 | 5 | 21670213 | |
| Pubmed | 8.91e-12 | 8 | 98 | 5 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 8.91e-12 | 8 | 98 | 5 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 8.91e-12 | 8 | 98 | 5 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 8.91e-12 | 8 | 98 | 5 | 28745977 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 2.00e-11 | 9 | 98 | 5 | 18394993 | |
| Pubmed | 2.00e-11 | 9 | 98 | 5 | 28100513 | ||
| Pubmed | 2.00e-11 | 9 | 98 | 5 | 17887960 | ||
| Pubmed | 2.00e-11 | 9 | 98 | 5 | 11553612 | ||
| Pubmed | 2.00e-11 | 9 | 98 | 5 | 10601307 | ||
| Pubmed | 2.00e-11 | 9 | 98 | 5 | 9733766 | ||
| Pubmed | 2.00e-11 | 9 | 98 | 5 | 28877029 | ||
| Pubmed | 3.08e-11 | 22 | 98 | 6 | 27717094 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 3.99e-11 | 10 | 98 | 5 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 3.99e-11 | 10 | 98 | 5 | 8857542 | |
| Pubmed | 3.99e-11 | 10 | 98 | 5 | 21859863 | ||
| Pubmed | 7.30e-11 | 11 | 98 | 5 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 7.30e-11 | 11 | 98 | 5 | 35771867 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 2.03e-10 | 13 | 98 | 5 | 31427429 | |
| Pubmed | RGPD4 FLII RGPD2 RANBP2 RANGAP1 EMC1 FRMPD4 RGPD8 DSG1 DNAJC16 SHOC2 SHANK3 ANO8 C2CD2L TENM4 RAB3GAP2 RGPD3 LRRC7 HNRNPLL | 3.97e-10 | 1139 | 98 | 19 | 36417873 | |
| Pubmed | 4.70e-10 | 15 | 98 | 5 | 14697343 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 2.06e-09 | 7 | 98 | 4 | 15710750 | |
| Pubmed | 5.08e-09 | 86 | 98 | 7 | 37253089 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.31e-08 | 153 | 98 | 8 | 26365490 | |
| Pubmed | 3.57e-08 | 33 | 98 | 5 | 19714462 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 7.47e-08 | 38 | 98 | 5 | 12791264 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 15539948 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 1.00e-07 | 370 | 98 | 10 | 22922362 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | DIP2B FLII EME1 RANBP2 RANGAP1 ATR RFC1 BLM FBXO38 RIF1 SETD2 ATM AGTPBP1 | 2.81e-07 | 774 | 98 | 13 | 15302935 |
| Pubmed | RGPD4 RGPD2 RANBP2 RGPD8 LCORL POLH DENND4C RLF RAB3GAP2 RGPD3 | 3.09e-07 | 418 | 98 | 10 | 34709266 | |
| Pubmed | 3.89e-07 | 99 | 98 | 6 | 27746211 | ||
| Pubmed | A general approach for investigating enzymatic pathways and substrates for ubiquitin-like modifiers. | 6.03e-07 | 24 | 98 | 4 | 16620772 | |
| Pubmed | Alternative Functions of Cell Cycle-Related and DNA Repair Proteins in Post-mitotic Neurons. | 8.41e-07 | 61 | 98 | 5 | 34746147 | |
| Pubmed | DNA damage repair machinery and HIV escape from innate immune sensing. | 1.20e-06 | 8 | 98 | 3 | 24795708 | |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 2.40e-06 | 135 | 98 | 6 | 31077711 | |
| Pubmed | RGPD4 DIP2B FLII RGPD2 RANBP2 RANGAP1 RGPD8 DOCK11 SHANK3 PTK2 RGPD3 GOLGA8B LRRC7 | 3.18e-06 | 963 | 98 | 13 | 28671696 | |
| Pubmed | SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. | 3.52e-06 | 11 | 98 | 3 | 11877377 | |
| Pubmed | 3.52e-06 | 11 | 98 | 3 | 15364958 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 3.78e-06 | 146 | 98 | 6 | 23892456 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 4.31e-06 | 231 | 98 | 7 | 16452087 | |
| Pubmed | RANBP2 EMC1 REPS1 INTS12 DNAJC16 DDX10 C2CD2L FARP2 BLM RIF1 SETD2 RBM19 RGPD3 ELAPOR1 HNRNPLL CDK7 | 4.33e-06 | 1497 | 98 | 16 | 31527615 | |
| Pubmed | 4.69e-06 | 12 | 98 | 3 | 10783165 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DIP2B HIVEP2 EMC1 INTS12 DOCK11 PARP8 BAD DENND4C RAB3GAP2 BICC1 AHNAK2 DOP1B | 5.68e-06 | 861 | 98 | 12 | 36931259 |
| Pubmed | 6.11e-06 | 42 | 98 | 4 | 18985028 | ||
| Pubmed | Single-stranded DNA orchestrates an ATM-to-ATR switch at DNA breaks. | 7.86e-06 | 2 | 98 | 2 | 19285939 | |
| Pubmed | Expression variations of DNA damage response genes ATM and ATR in blood cancer patients. | 7.86e-06 | 2 | 98 | 2 | 37338595 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 28851706 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 28620161 | ||
| Pubmed | Novel insights into the mechanism of cell cycle kinases Mec1(ATR) and Tel1(ATM). | 7.86e-06 | 2 | 98 | 2 | 34151669 | |
| Pubmed | Inhibition of Atm and/or Atr disrupts gene silencing on the inactive X chromosome. | 7.86e-06 | 2 | 98 | 2 | 16213462 | |
| Pubmed | The Nup358-RanGAP complex is required for efficient importin alpha/beta-dependent nuclear import. | 7.86e-06 | 2 | 98 | 2 | 18305100 | |
| Pubmed | Differential effects of desmoglein 1 and desmoglein 3 on desmosome formation. | 7.86e-06 | 2 | 98 | 2 | 12485422 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 27442013 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 24726882 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 26061708 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 20103595 | ||
| Pubmed | Interplay between ATM and ATR in the regulation of common fragile site stability. | 7.86e-06 | 2 | 98 | 2 | 17934520 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 25483091 | ||
| Pubmed | ATM and ATR activities maintain replication fork integrity during SV40 chromatin replication. | 7.86e-06 | 2 | 98 | 2 | 23592994 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 19527713 | ||
| Pubmed | Phosphorylation of the Bloom's syndrome helicase and its role in recovery from S-phase arrest. | 7.86e-06 | 2 | 98 | 2 | 14729972 | |
| Pubmed | Kinetic characterization of human histone H3 lysine 36 methyltransferases, ASH1L and SETD2. | 7.86e-06 | 2 | 98 | 2 | 26002201 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 26567218 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 33742106 | ||
| Pubmed | Expression of desmoglein 1 compensates for genetic loss of desmoglein 3 in keratinocyte adhesion. | 7.86e-06 | 2 | 98 | 2 | 12164920 | |
| Pubmed | Roles of ATM and ATR in DNA double strand breaks and replication stress. | 7.86e-06 | 2 | 98 | 2 | 33887296 | |
| Pubmed | ATR disruption leads to chromosomal fragmentation and early embryonic lethality. | 7.86e-06 | 2 | 98 | 2 | 10691732 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 31114877 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 35011623 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 1720352 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 26517239 | ||
| Pubmed | DNA damage-sensing kinases mediate the mouse 2-cell embryo's response to genotoxic stress. | 7.86e-06 | 2 | 98 | 2 | 21593482 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 25232030 | ||
| Pubmed | Cleavage of focal adhesion kinase by caspases during apoptosis. | 7.86e-06 | 2 | 98 | 2 | 9325343 | |
| Pubmed | ATM acts downstream of ATR in the DNA damage response signaling of bystander cells. | 7.86e-06 | 2 | 98 | 2 | 18757420 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 11927575 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 28820634 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 29279380 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 12526805 | ||
| Pubmed | Pemphigus IgG causes skin splitting in the presence of both desmoglein 1 and desmoglein 3. | 7.86e-06 | 2 | 98 | 2 | 17640963 | |
| Interaction | RGPD2 interactions | 2.40e-09 | 27 | 94 | 6 | int:RGPD2 | |
| Interaction | NUP43 interactions | EME1 RANBP2 RANGAP1 RGPD8 DSG1 POLH GPATCH1 ASH1L RFC1 BLM RLF RIF1 SETD2 RBM19 RAB3GAP2 AHNAK2 | 2.95e-08 | 625 | 94 | 16 | int:NUP43 |
| Interaction | RGPD4 interactions | 4.90e-08 | 22 | 94 | 5 | int:RGPD4 | |
| Interaction | RGPD1 interactions | 1.04e-07 | 49 | 94 | 6 | int:RGPD1 | |
| Interaction | RGPD3 interactions | 2.61e-06 | 47 | 94 | 5 | int:RGPD3 | |
| Interaction | RGPD5 interactions | 5.80e-06 | 96 | 94 | 6 | int:RGPD5 | |
| Interaction | RGPD8 interactions | 2.48e-05 | 74 | 94 | 5 | int:RGPD8 | |
| Cytoband | 11q22-q23 | 6.73e-05 | 6 | 98 | 2 | 11q22-q23 | |
| Cytoband | 10q25 | 2.45e-04 | 11 | 98 | 2 | 10q25 | |
| Cytoband | 2q12.3 | 6.01e-04 | 17 | 98 | 2 | 2q12.3 | |
| Cytoband | 18q12.1 | 1.42e-03 | 26 | 98 | 2 | 18q12.1 | |
| Cytoband | 20q11.2 | 1.53e-03 | 27 | 98 | 2 | 20q11.2 | |
| Cytoband | Xp21.1 | 2.42e-03 | 34 | 98 | 2 | Xp21.1 | |
| Cytoband | 9q33.2 | 3.17e-03 | 39 | 98 | 2 | 9q33.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q33 | 3.28e-03 | 138 | 98 | 3 | chr9q33 | |
| Cytoband | Xp22.2 | 3.34e-03 | 40 | 98 | 2 | Xp22.2 | |
| GeneFamily | Olfactory receptors, family 1 | 1.11e-05 | 40 | 63 | 4 | 147 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.00e-05 | 115 | 63 | 5 | 769 | |
| GeneFamily | PDZ domain containing | 1.87e-04 | 152 | 63 | 5 | 1220 | |
| GeneFamily | Desmosomal cadherins | 2.48e-04 | 7 | 63 | 2 | 1188 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 7.03e-04 | 50 | 63 | 3 | 1293 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 6.24e-03 | 34 | 63 | 2 | 487 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 1.37e-07 | 33 | 97 | 5 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 5.39e-07 | 43 | 97 | 5 | MM3857 | |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 2.30e-06 | 230 | 97 | 8 | M11563 | |
| Coexpression | GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN | 3.36e-06 | 170 | 97 | 7 | M6846 | |
| Coexpression | GSE3982_BCELL_VS_TH1_UP | 9.44e-06 | 199 | 97 | 7 | M5551 | |
| Coexpression | JAK2_DN.V1_DN | 1.82e-05 | 147 | 97 | 6 | M2872 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 3.46e-05 | 435 | 97 | 9 | MM1221 | |
| Coexpression | GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_DN | 7.45e-05 | 189 | 97 | 6 | M7555 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RANBP2 HIVEP2 ATR SHOC2 ZNF804A PTK2 DDX10 BLM RLF RIF1 SETD2 DOP1B | 7.62e-05 | 856 | 97 | 12 | M4500 |
| Coexpression | GSE3982_MAC_VS_NEUTROPHIL_DN | 8.85e-05 | 195 | 97 | 6 | M5492 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH1_UP | 9.89e-05 | 199 | 97 | 6 | M5564 | |
| Coexpression | GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN | 9.89e-05 | 199 | 97 | 6 | M5712 | |
| Coexpression | FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP | 1.00e-04 | 65 | 97 | 4 | M10243 | |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_UP | 1.02e-04 | 200 | 97 | 6 | M5074 | |
| Coexpression | GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN | 1.02e-04 | 200 | 97 | 6 | M5234 | |
| Coexpression | GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN | 1.02e-04 | 200 | 97 | 6 | M9777 | |
| Coexpression | MCGOWAN_RSP6_TARGETS_DN | 1.35e-04 | 5 | 97 | 2 | MM1227 | |
| Coexpression | MCGOWAN_RSP6_TARGETS_DN | 1.35e-04 | 5 | 97 | 2 | M1781 | |
| Coexpression | HAN_SATB1_TARGETS_UP | 1.84e-04 | 425 | 97 | 8 | M9639 | |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | NAALAD2 EMC1 DNAJC16 BAD SHOC2 DDX10 RLF SETD2 TENM4 CEP295 ATM | 1.97e-04 | 807 | 97 | 11 | M14594 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | NAALAD2 LCORL DOCK11 ASH1L PELI1 RLF RIF1 TENM4 CEP295 BICC1 CDK7 | 2.38e-06 | 413 | 95 | 11 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 8.59e-06 | 107 | 95 | 6 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.28e-05 | 275 | 95 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | NAALAD2 LCORL DOCK11 ASH1L PELI1 RFC1 RLF RIF1 TENM4 CEP295 BICC1 AHNAK2 CDK7 | 4.96e-05 | 790 | 95 | 13 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | RANGAP1 LCORL DOCK11 ASH1L PELI1 RFC1 DDX10 RLF RIF1 TENM4 CEP295 BICC1 CDK7 | 6.08e-05 | 806 | 95 | 13 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_100 | 1.26e-04 | 22 | 95 | 3 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k4_100 | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.27e-07 | 176 | 98 | 7 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.37e-06 | 193 | 98 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.24e-05 | 153 | 98 | 5 | 7480522a47e367f8facc4f5d599fbaf0b5ad4007 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.46e-05 | 156 | 98 | 5 | 53ded973358e3e48054130131e959f0d1f4ef60f | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-05 | 166 | 98 | 5 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.41e-05 | 167 | 98 | 5 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.41e-05 | 167 | 98 | 5 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-05 | 172 | 98 | 5 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.93e-05 | 172 | 98 | 5 | a9e13aa36087170dadca421ba9de588e5a1cf715 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-05 | 172 | 98 | 5 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Neutrophil|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.38e-05 | 176 | 98 | 5 | 676839d07450b313222622e0ffd305c732cbad6d | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.62e-05 | 178 | 98 | 5 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.62e-05 | 178 | 98 | 5 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.75e-05 | 179 | 98 | 5 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega|lymph-node_spleen / Manually curated celltypes from each tissue | 4.75e-05 | 179 | 98 | 5 | 4e0cf069bc47328eda753a4edc7e89b8915d52bb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-05 | 179 | 98 | 5 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.87e-05 | 180 | 98 | 5 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.87e-05 | 180 | 98 | 5 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 5.00e-05 | 181 | 98 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_Erythro-Mega-Megakaryocyte_early|bone_marrow / Manually curated celltypes from each tissue | 5.13e-05 | 182 | 98 | 5 | 1a755ea44daf8447a3a1c30de7fdb9c3888bcbde | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.41e-05 | 184 | 98 | 5 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega-Megakaryocyte_early|lymph-node_spleen / Manually curated celltypes from each tissue | 5.41e-05 | 184 | 98 | 5 | 10607d7d92edcbb92d992900086b90b307421cc3 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 5.41e-05 | 184 | 98 | 5 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.55e-05 | 185 | 98 | 5 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.55e-05 | 185 | 98 | 5 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-05 | 186 | 98 | 5 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.30e-05 | 190 | 98 | 5 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.30e-05 | 190 | 98 | 5 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-05 | 190 | 98 | 5 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 6.45e-05 | 191 | 98 | 5 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.45e-05 | 191 | 98 | 5 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.61e-05 | 192 | 98 | 5 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.78e-05 | 193 | 98 | 5 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.95e-05 | 194 | 98 | 5 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.12e-05 | 195 | 98 | 5 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.29e-05 | 196 | 98 | 5 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | Sigmoid-(1)_T_cell-(14)_Tcm|Sigmoid / shred on region, Cell_type, and subtype | 7.83e-05 | 199 | 98 | 5 | ec454fa22fb7f50a947bdf4c4bb6f0ba13f62b4c | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.83e-05 | 199 | 98 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Sigmoid-T_cell-Tcm|T_cell / Region, Cell class and subclass | 7.83e-05 | 199 | 98 | 5 | acdf95f4d58df47690f4ae254245bc618f9ac07e | |
| ToppCell | Sigmoid-T_cell-Tcm|Sigmoid / Region, Cell class and subclass | 7.83e-05 | 199 | 98 | 5 | f7c729eaa3c8fd5a05cb6f79cac9b8f199c8092b | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 98 | 5 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 98 | 5 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Club|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.02e-05 | 200 | 98 | 5 | 85f946dd3831acf3488c87efba96689cc2667c3a | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-05 | 200 | 98 | 5 | 8a44a4f7ea9358f2194a490e79601c98ff7fdcb0 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.02e-05 | 200 | 98 | 5 | 30d428510c68da96c7c8cfd472f449ebb9631132 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 98 | 5 | 320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.10e-04 | 50 | 54 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Bhpp | 9.00e-08 | 27 | 96 | 5 | CID000164136 | |
| Drug | DCNP | 1.11e-05 | 33 | 96 | 4 | CID000012066 | |
| Drug | abietane | 1.17e-05 | 11 | 96 | 3 | CID006857485 | |
| Drug | CPG-oligonucleotide | 1.31e-05 | 184 | 96 | 7 | ctd:C408982 | |
| Drug | perhydrophenanthrene | 1.76e-05 | 2 | 96 | 2 | CID000021971 | |
| Drug | Iobenguane sulfate; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.10e-05 | 198 | 96 | 7 | 2878_UP | |
| Drug | 1,2-naphthoquinone | 2.41e-05 | 40 | 96 | 4 | CID000010667 | |
| Drug | bis(2,4,6-trichlorophenyl)oxalate | 2.56e-05 | 14 | 96 | 3 | CID000160567 | |
| Drug | AC1L1H1K | 2.67e-05 | 41 | 96 | 4 | CID000003935 | |
| Drug | 4-hydroxy-2-nonenal | CDKN1C EME1 CALR3 HIVEP2 ATR RBL1 POLH BAD CASP7 SHOC2 PTK2 BLM ATM | 3.02e-05 | 798 | 96 | 13 | ctd:C027576 |
| Drug | acepyrene | 4.73e-05 | 17 | 96 | 3 | CID000033743 | |
| Drug | entadamide A | 5.26e-05 | 3 | 96 | 2 | CID006439215 | |
| Drug | p-nitrophenyl vinyl ether | 5.26e-05 | 3 | 96 | 2 | CID000119042 | |
| Drug | 3-hydroxyisoscopoletin | 5.26e-05 | 3 | 96 | 2 | CID000196821 | |
| Drug | 3-hydroxyscopoletin | 5.26e-05 | 3 | 96 | 2 | CID005492606 | |
| Drug | gamma-asarone | 5.26e-05 | 3 | 96 | 2 | CID000636750 | |
| Drug | xanthoxylol | 5.26e-05 | 3 | 96 | 2 | CID000130679 | |
| Drug | entadamide B | 5.26e-05 | 3 | 96 | 2 | CID003035981 | |
| Drug | 3-hydroxyumbelliferone | 5.26e-05 | 3 | 96 | 2 | CID006918810 | |
| Disease | brachydactyly type A2 (implicated_via_orthology) | 9.83e-06 | 2 | 93 | 2 | DOID:0110965 (implicated_via_orthology) | |
| Disease | ataxia telangiectasia (implicated_via_orthology) | 9.83e-06 | 2 | 93 | 2 | DOID:12704 (implicated_via_orthology) | |
| Disease | leukemia | 2.79e-05 | 55 | 93 | 4 | C0023418 | |
| Disease | serum gamma-glutamyl transferase measurement | REPS1 LCORL DOCK11 DNAJC16 GPATCH1 ASH1L ZNF804A FARP2 SETD2 TENM4 CDH6 BICC1 | 3.02e-05 | 914 | 93 | 12 | EFO_0004532 |
| Disease | response to interferon-beta | 2.04e-04 | 7 | 93 | 2 | GO_0035456 | |
| Disease | Tourette syndrome, bipolar disorder | 2.04e-04 | 7 | 93 | 2 | EFO_0004895, MONDO_0004985 | |
| Disease | mean reticulocyte volume | 2.14e-04 | 799 | 93 | 10 | EFO_0010701 | |
| Disease | female breast cancer (is_implicated_in) | 2.72e-04 | 8 | 93 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | pregnanediol-3-glucuronide measurement | 2.72e-04 | 8 | 93 | 2 | EFO_0800341 | |
| Disease | colon cancer (implicated_via_orthology) | 5.31e-04 | 11 | 93 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 5.34e-04 | 50 | 93 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | VWF POLH CASP7 RFX2 DDX10 RIF1 SETD2 ELAPOR1 LRRC7 ATM REPS2 | 5.64e-04 | 1074 | 93 | 11 | C0006142 |
| Disease | rotator cuff tear, shoulder impingement syndrome | 6.35e-04 | 12 | 93 | 2 | EFO_1001178, EFO_1001250 | |
| Disease | Malignant Neoplasms | 7.32e-04 | 128 | 93 | 4 | C0006826 | |
| Disease | Prostatic Neoplasms | 7.41e-04 | 616 | 93 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 7.41e-04 | 616 | 93 | 8 | C0376358 | |
| Disease | gastric ulcer (implicated_via_orthology) | 8.72e-04 | 14 | 93 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | posterior thigh muscle volume | 1.00e-03 | 15 | 93 | 2 | EFO_0020931 | |
| Disease | urinary metabolite measurement | 1.09e-03 | 245 | 93 | 5 | EFO_0005116 | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.25e-03 | 67 | 93 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | X-21441 measurement | 1.30e-03 | 17 | 93 | 2 | EFO_0800814 | |
| Disease | Benign neoplasm of stomach | 1.30e-03 | 17 | 93 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.30e-03 | 17 | 93 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.30e-03 | 17 | 93 | 2 | C0154060 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.30e-03 | 17 | 93 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | schizophrenia (implicated_via_orthology) | 1.31e-03 | 68 | 93 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | Alzheimer's disease (is_marker_for) | 1.34e-03 | 257 | 93 | 5 | DOID:10652 (is_marker_for) | |
| Disease | metabolonic lactone sulfate measurement | 1.62e-03 | 19 | 93 | 2 | EFO_0800659 | |
| Disease | leukemia (implicated_via_orthology) | 1.62e-03 | 19 | 93 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | Stomach Carcinoma | 1.98e-03 | 21 | 93 | 2 | C0699791 | |
| Disease | Immunologic Deficiency Syndromes | 2.38e-03 | 23 | 93 | 2 | C0021051 | |
| Disease | infant body height | 2.38e-03 | 23 | 93 | 2 | EFO_0006785 | |
| Disease | Autism Spectrum Disorders | 2.48e-03 | 85 | 93 | 3 | C1510586 | |
| Disease | squamous cell lung carcinoma, family history of lung cancer | 2.48e-03 | 85 | 93 | 3 | EFO_0000708, EFO_0006953 | |
| Disease | breast cancer (implicated_via_orthology) | 2.81e-03 | 25 | 93 | 2 | DOID:1612 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FSNKPFLKLGAVSAS | 676 | Q9NR48 | |
| AISARFKPFSNKGKT | 76 | Q96L12 | |
| FVDSFKKGLPRPKSA | 121 | Q92934 | |
| NSSDLSAKPKFSKPF | 866 | Q5T601 | |
| STKKFLKFGFLDPLF | 206 | P20815 | |
| FSFTLGKLPRKTLSV | 231 | Q9BXJ3 | |
| LFTASPRFKALLSSK | 941 | A6QL63 | |
| SSFKGSDLPELFSKL | 871 | Q9H694 | |
| FKIIGPFSKKNSSLI | 206 | Q9UPW5 | |
| LPAFLSFKFLKSPET | 1021 | Q9HCE9 | |
| RKSSAQGKPLALKVF | 171 | P46060 | |
| FKSALSPSKSPAKLN | 2271 | P49792 | |
| DSLTKKPKGFAFITF | 436 | Q9Y4C8 | |
| KRIFSSEKSKPFAFG | 1546 | O14715 | |
| KVFDAKPSAKTLSGL | 486 | Q8WVV9 | |
| PIFLKALGFLHSKSK | 11 | Q96CB8 | |
| KPSFLKALLATFGSS | 296 | O15438 | |
| KFTRPLFKDLAAFDK | 566 | P09960 | |
| VKPLSLFDSKGKNAF | 1176 | Q9H2M9 | |
| LDDSFLDSLGPKFKK | 841 | P32926 | |
| AALFSKLSPAQPARK | 101 | Q5HY64 | |
| PKAEAPALFSRTASK | 236 | Q16849 | |
| PPAKESNFRAAKKLF | 676 | Q8N3A8 | |
| TFSLQKKFESLFPGK | 1001 | Q13045 | |
| KAGSVPSSFLLKKAR | 136 | P43026 | |
| KNLPFSFTKLKELAA | 381 | Q96NW7 | |
| PSFKFRGHKSALLSK | 961 | Q9Y6X6 | |
| LSDLFTARGSPFKTK | 696 | Q9Y3R5 | |
| PAGKPASFKNKTRDF | 316 | Q8N3X6 | |
| LFGKIKSFTSKRTPD | 981 | Q6UXG2 | |
| LKKLFSALGQSSRPK | 1006 | Q5VZ46 | |
| LDGFSLASKPLSSKK | 346 | Q9BRR8 | |
| ATLKASNFKPFAKDP | 496 | Q9BRR8 | |
| KIFTKRSLSPSKRGF | 461 | Q1X8D7 | |
| TKLSKPFEAFLSFAL | 396 | Q9Y2G8 | |
| QSFSKLFKDIGLSPR | 1296 | Q9P265 | |
| LSPGLAADFLLKAFK | 401 | Q8IVH4 | |
| KKTSIFINLSPEFKG | 1016 | P98088 | |
| SFLDTLGPKFKKLAD | 746 | Q02413 | |
| SFPKKKAALLSAAIL | 1046 | Q5TIA1 | |
| LKAPSTKGIFKALST | 226 | Q8NGS1 | |
| LKIPSAQGKRKAFST | 226 | P47890 | |
| LKIPSAAGKRKAFST | 276 | Q8NH94 | |
| PSGFTDASFLTLLKK | 86 | Q6PIJ6 | |
| FKSALSLSKSPAKLN | 1296 | A6NKT7 | |
| TKKSPNKIASGFFLR | 791 | Q13315 | |
| LFLFKSKSPAIFGVL | 131 | Q13535 | |
| LNNKLSLSKPKFSGF | 21 | P54132 | |
| KFTKRLSKPGTAAEL | 6 | Q5JSL3 | |
| LIKRFSFKSKPKANG | 686 | O14523 | |
| KLSGPLISDFFAKRK | 266 | P49918 | |
| LKLADFGLAKSFGSP | 151 | P50613 | |
| PSPKSAFISAAKKAR | 156 | Q14CM0 | |
| AFISAAKKARLKSNP | 161 | Q14CM0 | |
| EFKDLRGSASFFLKP | 1536 | Q5VZ89 | |
| PDRSSFVPSLFSKKK | 26 | P55210 | |
| FPAKKRALELSGNSK | 31 | P55285 | |
| KFASLEFSPGSKKLV | 41 | Q8N766 | |
| PTFAFLKKEPSSTKR | 21 | Q96AY2 | |
| FSDFPLSKKTLKGLQ | 71 | Q13206 | |
| TQSFSKLFKDLGLPA | 1291 | Q14689 | |
| PNRKFPSSSVAFKLS | 106 | Q5T890 | |
| KPDGFSSRSKALLKR | 186 | A8MQT2 | |
| PKPKAKAVFFSRGSS | 326 | O94887 | |
| PGSLQEAFIKRKKSF | 2476 | Q9C0D2 | |
| FALFKRPKANGVKPS | 41 | Q96FA3 | |
| VLKIPSTSGKRKAFS | 226 | Q8NGR8 | |
| GFSFKLNLSTRPEKF | 491 | P26639 | |
| PKRKGFLLSKFRSAT | 181 | Q8TDW5 | |
| FKSALSPSKSPAKLN | 1296 | Q7Z3J3 | |
| GSAAKEFFTKSKLPI | 306 | Q96D71 | |
| PFFKGSILSRLKKES | 251 | Q9H5Y7 | |
| ALLYKFNGSPSKSLK | 1001 | P28749 | |
| GSPSFPKAARQFLLK | 601 | P48378 | |
| FSKLDPKVKAAFTRA | 1051 | P35251 | |
| FSFKSALSLSKSPAK | 1286 | P0DJD1 | |
| FLPKAKQREGTFSKS | 1261 | Q5UIP0 | |
| FFERGKSATLSLPKA | 16 | Q7RTZ1 | |
| FFPKSLLDSVKAKTL | 206 | Q05397 | |
| PFGIFSRAKVLSKLN | 371 | Q9UQ13 | |
| TGTEPFFKQKSLLLK | 526 | Q9Y253 | |
| DSSQTFRPKFLALKG | 311 | Q9NY99 | |
| PIQLFPKSFFSSKAK | 101 | Q06520 | |
| SLGFAKPDLRSSKAK | 5096 | Q8IVF2 | |
| DTAKKGFFSKPSLRS | 326 | Q8N1B4 | |
| AKKPRAFKGTDLSNL | 231 | Q4W5G0 | |
| KSFAKAFISKANIGP | 1711 | P04275 | |
| LSSGFFSPKQPDLFK | 746 | P11217 | |
| AKNFFTKSKLSIPEL | 306 | Q8NFH8 | |
| SKFSTPILDLFPTKK | 1891 | Q13129 | |
| AKKSPIAAARLFSSL | 1526 | Q9BYB0 | |
| VFSFLGLKPRLASKA | 91 | Q9UJC5 | |
| STFARPAFNLKKPSK | 321 | Q6N022 | |
| SAKVSPGFNSLSFKK | 31 | Q96MV1 | |
| SSRFLPKGTKTKVNL | 51 | Q9BYW2 | |
| FIKSKFSFNLRKPSV | 86 | A0A0A6YYK1 | |
| KPDASFLFGSKLERK | 1731 | P31629 | |
| FFKGLSPSLLKAALS | 281 | Q9HC21 | |
| FAFPKKASVKLESSA | 216 | Q7Z570 | |
| SGSSLFSRKKFSPPK | 266 | Q8TF71 | |
| KSFLRSFTKLPHLAG | 61 | Q9Y3Q0 |